Bedside Local Thrombolysis in Patients with Massive Pulmonary Embolism and No Access to Fluoroscopy: a New Tool in the Intensivist's Arsenal?
Marco Zuin,Gianluca Rigatelli
DOI: https://doi.org/10.1016/j.bja.2018.10.057
IF: 11.719
2019-01-01
British Journal of Anaesthesia
Abstract:Management and treatment of haemodynamically unstable patients with acute pulmonary embolism (PE) often represents a challenge for intensivists. Over the past two decades, many investigations have demonstrated that systemic thrombolysis in haemodynamically unstable patients, labelled as high-risk or massive PE according to European and American nomenclature, respectively, reduces short-term mortality.1Marti C. John G. Konstantinides S. et al.Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis.Eur Heart J. 2015; 36: 605-614Crossref PubMed Scopus (287) Google Scholar International guidelines have specified several exclusion criteria for systemic thrombolysis including recent major surgery, stroke, trauma, and clinical conditions related to high bleeding risk.2Konstantinides S.V. Torbicki A. Agnelli G. et al.Task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). ESC guidelines on the diagnosis and management of acute pulmonary embolism.Eur Heart J. 2014; 35: 3033-3069Crossref PubMed Scopus (2190) Google Scholar All these clinical situations are commonly observed in ICUs. This clinical scenario frequently generates debate among intensivists regarding optimal therapeutic management, especially when absolute, relative, or both types of contraindications to systemic thrombolysis are present. In the latest international guidelines on acute PE, catheter-directed thrombolysis (CDT) is suggested as a potential alternative treatment. CDT allows targeted drug delivery directly into the thrombus for optimal effect, thereby allowing a lower thrombolytic dose and less risk of bleeding complications. However, despite several devices and methods currently available with which to perform CDT, this interventional approach remains often unavailable and underused owing to a lack of widespread expertise and local resource availability.3Zuin M. Kuo W.T. Rigatelli G. Daggubati R. Vassiliev D. Roncon L. Catheter-directed therapy as a first-line treatment strategy in hemodynamically unstable patients with acute pulmonary embolism: yes or no?.Int J Cardiol. 2016; 225: 14-15Abstract Full Text Full Text PDF PubMed Scopus (13) Google Scholar If CDT is not promptly available and patients have absolute contraindications to systemic thrombolysis, what can we do in the ICU? Isolated reports have proposed bedside administration of local thrombolytic therapy in high-risk PE patients via a trans-jugular Swan-Ganz pulmonary artery catheter.4Espina I. Varon J. Lin P.H. Thrombolytic therapy of acute massive pulmonary embolism using Swan-Ganz pulmonary artery catheter.Ann Vasc Surg. 2017; 43: 315Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar, 5Karahaliou A. Papathanasiou A. Andrianopoulos I. et al.Thrombolysis through a Swan-Ganz catheter in two patients with high-risk pulmonary embolism and absolute contraindication for systemic thrombolysis.Hellenic J Cardiol. 2017; S1109-9666 (30463-3)https://doi.org/10.1016/j.hjc.2017.11.008Crossref Scopus (3) Google Scholar A review of literature on local administration of thrombolytic drugs in patients with acute PE was conducted using the PubMed database. Relevant case reports in English were identified using a combined text word and Medical Subject Headings (MeSH) search strategy with the following combination of keywords: Swan-Ganz thrombolysis and PE, Thrombolytic therapy in PE and Swan-Ganz, and Swan-Ganz and PE. The search, conducted in September 2018, identified three published case reports (Table 1). All subjects had a high-risk (massive) PE, absolute contraindications to receive systemic thrombolysis, and in all cases, CDT was unavailable in the institution where the patients were admitted. Local administration of tissue plasminogen activator (tPA) through a Swan-Ganz catheter represents an appealing bedside alternative to standard CDT, which requires special facilities with fluoroscopy. Placement of a Swan-Ganz catheter is a procedure commonly performed in ICUs and does not require any specific or expensive devices as needed for CDT.Table 1Case reports reporting the bedside local administration of alteplase, in patients with acute pulmonary embolism via pulmonary artery catheter. ESC, European Society of Cardiology; NR, not reported; RVD, right ventricular dysfunction; tPA, tissue plasminogen activator.AuthorYearSexAge (yr)Type of PE according the ESC classification [American classification]RVDMechanical ventilationVasopressor supportContraindication to thrombolysisDose of tPA via pulmonary artery catheter [total dose]Effect of local thrombolysisEspina and colleagues4Espina I. Varon J. Lin P.H. Thrombolytic therapy of acute massive pulmonary embolism using Swan-Ganz pulmonary artery catheter.Ann Vasc Surg. 2017; 43: 315Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar2017♀78High-risk [massive]YesYesYesNot specified; owing to rapid haemodynamic deterioration impossible to transfer to a tertiary medical facility50 mg followed by continual infusion maintained at 1 mg h−1 [NR]•Significant haemodynamic improvement after 3 h from the infusion•Extubated 2 days later•Maintained only in oral anticoagulation•One-year follow-up uneventfulKarahaliou and colleagues5Karahaliou A. Papathanasiou A. Andrianopoulos I. et al.Thrombolysis through a Swan-Ganz catheter in two patients with high-risk pulmonary embolism and absolute contraindication for systemic thrombolysis.Hellenic J Cardiol. 2017; S1109-9666 (30463-3)https://doi.org/10.1016/j.hjc.2017.11.008Crossref Scopus (3) Google Scholar2017♀27High-risk [massive]YesYesYesHaemorrhagic shock after elective Caesarean section requiring hysterectomy3 mg (bolus) followed by continues infusion of 1 mg h−1 [20 mg]•Significant haemodynamic improvement after 6 h•Vasopressors withdrawal•Lactic acidosis resolved•Urine output restored•RV function improvedKarahaliou and ∖colleagues5Karahaliou A. Papathanasiou A. Andrianopoulos I. et al.Thrombolysis through a Swan-Ganz catheter in two patients with high-risk pulmonary embolism and absolute contraindication for systemic thrombolysis.Hellenic J Cardiol. 2017; S1109-9666 (30463-3)https://doi.org/10.1016/j.hjc.2017.11.008Crossref Scopus (3) Google Scholar2017♂63High-risk [massive]YesYesYesSubarachnoid haemorrhage and brain contusion after trauma3 mg (bolus) followed by continues infusion of 1 mg h−1 [20 mg]•Significant haemodynamic improvement•Vasopressors withdrawal•Lactic acidosis resolved•RV function improved after 11 h Open table in a new tab The few cases described represent a major limitation in assessing this new reperfusion technique. Clinical and technical aspects must be clarified before recommending this procedure as a rescue treatment. Possible severe arrhythmic events during pulmonary artery placement, possible concomitant presence of right-sided endocarditis or right atrial or ventricular floating thrombus, or the presence of thrombocytopenia or coagulopathy that can complicate the sheath insertion, must be considered as absolute/relative contraindications. Furthermore, catheter embolisation and arterial perforation are rare but possible complications. The cited reports used electrocardiographic and pressure-wave monitoring to confirm the correct positioning of the pulmonary artery catheter. Subsequently, a chest radiograph was performed to determine the position of the catheter tip and rule out pneumothorax. However, as detection of postoperative pulmonary complications using chest radiography is limited, lung ultrasound can be used as the primary imaging technique to detect postoperative pulmonary complications, enhancing bedside decision-making.6Piette E. Daoust R. Denault A. Basic concepts in the use of thoracic and lung ultrasound.Curr Opin Anaesthesiol. 2013; 26: 20-30Crossref PubMed Scopus (51) Google Scholar The appropriate position of the catheter in the pulmonary arterial system is crucial to achieve selective local thrombolysis. To obtain ideal catheter placement, especially when the thrombus involves only a single pulmonary branch or a segmental artery, and to minimise the distribution of the drug into the total pulmonary artery circulation, we believe that an echocardiography-guided approach is preferable. Both transthoracic (TTE) and transoesophageal echocardiography (TOE) allow direct visualisation of the pulmonary artery bifurcation, the former using a parasternal short-axis view and the latter through a 0° plane. The pressure waveforms obtained via the Swanz-Ganz catheter are only able to confirm its location in the right atrium, ventricle, or pulmonary artery. Potentially, after diagnostic confirmation of PE, determination of thrombus location, and exclusion of a right-side floating thrombus, the Swanz-Ganz catheter could be inserted using a trans-jugular approach and precisely placed under echocardiographic guidance, allowing insertion of the catheter tip only in a branch or at the main pulmonary artery bifurcation in case of bilateral or multiple thrombi. Clearer visualisation of the tip during placement could be potentially achieved by inflating the catheter's balloon with ultrasound contrast media instead of air. Use of TTE or TOE depends on physician skills, patient haemodynamic impairment (as TOE can require mild sedation), local resources, and quality of the acoustic window with TTE. A limitation of interventional treatments in acute PE is the absence of large-scale studies or comparative trials. However, as with this technique, it may not be feasible to conduct randomised trials as many patients would be excluded because of contraindications to systemic thrombolysis. Moreover, it would not be ethical to randomise patients dying from massive PE. Large registries will be required to detect safety and efficacy of interventional radiology and local thrombolysis provided through a pulmonary catheter. In the meantime, use of bedside thrombolysis through a pulmonary artery can be considered an off-label potential rescue therapy in life-threating situations. As no data regarding the effective dose of tPA are available for this novel interventional approach, we suggest the same dose recommended by international guidelines for standard CDT.2Konstantinides S.V. Torbicki A. Agnelli G. et al.Task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). ESC guidelines on the diagnosis and management of acute pulmonary embolism.Eur Heart J. 2014; 35: 3033-3069Crossref PubMed Scopus (2190) Google Scholar Potential adverse events related to administration of tPA through a Swan-Ganz catheter must also be considered. Thrombolytic therapy is generally administered via a 4 French sheath, whereas a Swan-Ganz catheter requires a 7 French introducer. The larger sheath size could be related to a higher risk of haemorrhagic complications as a result of continuous thrombolytic infusion. Moreover, systemic distribution of tPA cannot be ruled out. Further studies are required to confirm the safety and efficacy of this novel reperfusion technique to dissolve a thrombus with a lower dose of thrombolytic drug. Conception, design, acquisition of data, and interpretation: MZ, GR, LR. Drafting of the manuscript: MZ, GR. Critical revision and final approval of the manuscript: LR. The authors declare that they have no conflicts of interest.